(Thanks to Israel21c) Israel’s Orgenesis is a pioneer in the field of “cellular trans-differentiation”, a process to transform a type 1 diabetic patient’s own liver cells into new insulin-producing cells. Orgenesis is partnering with Belgium’s MaSTherCell to scale up development.
http://www.israel21c.org/news/orgenesis-masthercell-to-scale-manufacturing-of-insulin-producing-liver-cells/